These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 12707406)

  • 1. Extracellular matrix metabolism in diabetic nephropathy.
    Mason RM; Wahab NA
    J Am Soc Nephrol; 2003 May; 14(5):1358-73. PubMed ID: 12707406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormality of type IV collagen metabolism in the development of diabetic nephropathy].
    Haneda M; Kikkawa R
    Nihon Rinsho; 1992 Dec; 50(12):3016-20. PubMed ID: 1491453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.
    Hu C; Sun L; Xiao L; Han Y; Fu X; Xiong X; Xu X; Liu Y; Yang S; Liu F; Kanwar YS
    Curr Med Chem; 2015; 22(24):2858-70. PubMed ID: 26119175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
    van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
    Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy.
    Olgemöller B; Schleicher E
    Clin Investig; 1993; 71(5 Suppl):S13-9. PubMed ID: 8518535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.
    Abe H; Matsubara T; Arai H; Doi T
    Histol Histopathol; 2011 Apr; 26(4):531-41. PubMed ID: 21360446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of leucocyte proteolytic enzyme activity in diabetic patients with microalbuminuria and proteinuria: its possible role in diabetic nephropathy.
    McLennan SV; Zilkens RR; Yue DK; Turtle JR
    Diabet Med; 1996 Feb; 13(2):145-9. PubMed ID: 8641119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy and advanced glycation end products.
    Menè P; Festuccia F; Polci R; Pugliese F; Cinotti GA
    Contrib Nephrol; 2001; (131):22-32. PubMed ID: 11125560
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative stress in diabetic nephropathy: basic and clinical information.
    Ha H; Lee HB
    Curr Diab Rep; 2001 Dec; 1(3):282-7. PubMed ID: 12643211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney.
    Ha H; Lee HB
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S7-10. PubMed ID: 16174288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.
    Makino H; Shikata K; Hironaka K; Kushiro M; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
    Kidney Int; 1995 Aug; 48(2):517-26. PubMed ID: 7564121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression.
    Wu P; Wang Y; Davis ME; Zuckerman JE; Chaudhari S; Begg M; Ma R
    J Am Soc Nephrol; 2015 Nov; 26(11):2691-702. PubMed ID: 25788524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy.
    Lee HB; Yu MR; Yang Y; Jiang Z; Ha H
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S241-5. PubMed ID: 12874439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.
    Nerlich A; Schleicher E
    Am J Pathol; 1991 Oct; 139(4):889-99. PubMed ID: 1928305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephronectin expression in glomeruli of renal biopsy specimens from various kidney diseases: nephronectin is expressed in the mesangial matrix expansion of diabetic nephropathy.
    Nakatani S; Ishimura E; Mori K; Fukumoto S; Yamano S; Wei M; Emoto M; Wanibuchi H; Inaba M
    Nephron Clin Pract; 2012; 122(3-4):114-21. PubMed ID: 23689482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of advanced glycation end-products in the progression of diabetic nephropathy.
    Makino H; Shikata K; Kushiro M; Hironaka K; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
    Nephrol Dial Transplant; 1996; 11 Suppl 5():76-80. PubMed ID: 9044313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of intracellular redox state by extracellular matrix proteins in glomerular mesangial cells: potential role in diabetic nephropathy.
    Nakajima T; Hasegawa G; Kamiuchi K; Fukui M; Yamasaki M; Tominaga M; Asano M; Hosoda H; Yoshikawa T; Nakamura N
    Redox Rep; 2006; 11(5):223-30. PubMed ID: 17132271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy.
    Falk RJ; Scheinman JI; Mauer SM; Michael AF
    Diabetes; 1983 May; 32 Suppl 2():34-9. PubMed ID: 6400667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.